Literature DB >> 7545742

Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas.

J J Larson1, H R van Loveren, M G Balko, J M Tew.   

Abstract

Anatomical and biological studies of cavernous sinus meningiomas help us understand the biological heterogeneity of these tumors. The question of whether cavernous sinus meningiomas infiltrate cranial nerves is clinically important because of the effect on treatment planning. In the authors' experience of treating 36 patients with cavernous sinus meningiomas, tumor invasion into a cranial nerve was documented in two patients in whom a cranial nerve was resected during the cavernous sinus dissection. In both patients, histological examination using hematoxylin and eosin and bodian stains showed infiltration of the cranial nerves by a benign meningioma which, to the best of the authors' knowledge, is a condition previously unreported. This histological finding of meningioma invasion into a cranial nerve demonstrates the biological heterogeneity of cavernous sinus meningiomas and raises concern about the invasive character of meningioma. Because not all tumor cells can be identified radiologically or by direct visualization at surgery, occult tumor infiltration predisposes a patient to recurrence despite the best neurosurgical efforts. Evidence of cranial nerve infiltration by meningioma suggests that, in some circumstances, cavernous sinus dissection in the hope of total removal of a meningioma may be futile and, in the long term, may provide no advantage over treatment options with lower morbidity.

Entities:  

Mesh:

Year:  1995        PMID: 7545742     DOI: 10.3171/jns.1995.83.4.0596

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

Review 1.  Trigeminal complications arising after surgery of cranial base meningiomas.

Authors:  Ulf Westerlund; Bengt Linderoth; Tiit Mathiesen
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

Review 2.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

Review 3.  Contemporary surgical outcome for skull base meningiomas.

Authors:  Chien-Min Chen; Abel Po-Hao Huang; Lu-Ting Kuo; Yong-Kwang Tu
Journal:  Neurosurg Rev       Date:  2011-05-26       Impact factor: 3.042

4.  Cavernous Sinus Meningioma with Orbital Involvement: Algorithmic Decision-Making and Treatment Strategy.

Authors:  Amol Raheja; William T Couldwell
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-17

Review 5.  Hereditary genodermatoses with cancer predisposition.

Authors:  Meg R Gerstenblith; Alisa M Goldstein; Margaret A Tucker
Journal:  Hematol Oncol Clin North Am       Date:  2010-10       Impact factor: 3.722

6.  Cavernous sinus meningiomas: a large LINAC radiosurgery series.

Authors:  Roberto Spiegelmann; Zvi R Cohen; Ouzi Nissim; Dror Alezra; Raphael Pfeffer
Journal:  J Neurooncol       Date:  2010-04-20       Impact factor: 4.130

7.  Stereotactic LINAC radiosurgery for the treatment of typical intracranial meningiomas. Efficacy and safety after a follow-up of over 12 years.

Authors:  Mustafa El-Khatib; Faycal El Majdoub; Stefan Hunsche; Mauritius Hoevels; Martin Kocher; Volker Sturm; Mohammad Maarouf
Journal:  Strahlenther Onkol       Date:  2015-08-08       Impact factor: 3.621

Review 8.  Management options for cavernous sinus meningiomas.

Authors:  Michael T Walsh; William T Couldwell
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  A prospective study of cavernous sinus surgery for meningiomas and resultant common ophthalmic complications (an American Ophthalmological Society thesis).

Authors:  Steven Newman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

10.  Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.

Authors:  Kenichiro Iwami; Atsushi Natsume; Masasuke Ohno; Hiroaki Ikeda; Junichi Mineno; Ikuei Nukaya; Sachiko Okamoto; Hiroshi Fujiwara; Masaki Yasukawa; Hiroshi Shiku; Toshihiko Wakabayashi
Journal:  Neuro Oncol       Date:  2013-03-03       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.